Phage therapy at BIOASTER

#PhageTherapy at BIOASTER At @Bioaster, we have developed #preclinicalModels allowing To follow the concentration of #phages over time (#pharmacokinetics) in different fluids and organs after administration by various routes On...

BLOOD-ON-CHIP INITIATIVE

BIOASTER and Institut Pasteur are proud to join forces to build a novel microphysiological system (MPS) mimicking the first steps of immune activation during vaccination. This system will enable studying...

New publication about COVID-19 vaccine on eBioMedicine

The COVID19-101 project in partnership with the Institut Pasteur aimed to characterize the immune response induced by the SARS-CoV-2 vaccine candidate as part of a phase I clinical study. This...

New Publication from REALISM Project in Frontier Immunol.

New publication from REALISM collaborative project in Frontiers in Immunology about Herpes DNAemia & TTV Viraemia in Intenisve Care unit entilted: “Herpes DNAemia and TTV Viraemia in Intensive Care Unit...

New APPLICATION NOTE available on Proteomics with COVARIS

New Application note available in collaboration with COVARIS entitled: A Robust and Standardized Workflow to Analyze C. albicans differential Protein Expression using Tandem Mass Tag (TMT) Abstract Yeast samples are...

BIOASTER publishes a new article in Frontiers in Immunology .

BIOASTER in collaboration with Cochin Hospital and the REALISM project consortium (study of the pathophysiology of intensive care patients and on biomarkers), has just published the article entitled “Assessing the...